Stocktoria

Fortress Biotech, Inc. FBIO

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2011-11-17 · LEI

Fortress Biotech, Inc. statistics & valuation

Market cap$91.7M
P / E13.5×
P / S1.4×
P / B1.5×
Dividend yield0.72%
Net margin10.8%
Return on equity11.0%
Net cash$24.9M
Enterprise value USD$66.8M
Earnings yield EBIT/EV-105.1%
Return on capital-51.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-334.30% -35.70% -313.00% -109.10% -102.00% -94.10% -114.30% -71.70% -79.80% 10.80% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-398.70% -47.90% -446.40% -302.50% -206.70% -274.10% -268.80% -168.40% -191.40% -111.00% 2016201720182019202020212022202320242025
Return on equity (%)
-66.40% -55.50% -426.20% -55.10% -23.60% -28.60% -173.10% -269.00% -202.30% 11.00% 2016201720182019202020212022202320242025
Shares outstanding
48.9M 51.0M 57.8M 74.0M 94.9M 101.4M 7.4M 15.1M 27.9M 31.4M 2016201720182019202020212022202320242025
Net debt ($)
-$75.0M -$27.4M $18.9M -$52.2M -$181.7M -$262.8M -$86.5M -$20.1M $699000 -$24.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-32.30% -27.20% -59.70% -17.60% -14.00% -16.30% -29.40% -36.20% -31.90% 3.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-316.60% -43.70% -394.10% -265.70% -187.70% -176.00% -240.40% -151.80% -139.00% 2016201720182019202020212022202320242025
Debt / equity (×)
0.36× 0.56× 4.28× 1.17× 0.26× 0.19× 1.83× 2.70× 2.55× 0.88× 2016201720182019202020212022202320242025
EPS ($)
-$0.79 -$15.97 -$8.47 -$2.69 -$0.07 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-111.0%-191.4%-168.4%-268.8%-274.1%-206.7%-302.5%-446.4%-47.9%-398.7%
Net margin10.8%-79.8%-71.7%-114.3%-94.1%-102.0%-109.1%-313.0%-35.7%-334.3%
FCF margin—-139.0%-151.8%-240.4%-176.0%-187.7%-265.7%-394.1%-43.7%-316.6%
Return on assets3.7%-31.9%-36.2%-29.4%-16.3%-14.0%-17.6%-59.7%-27.2%-32.3%
Return on equity11.0%-202.3%-269.0%-173.1%-28.6%-23.6%-55.1%-426.2%-55.5%-66.4%
Debt / equity0.88×2.55×2.70×1.83×0.19×0.26×1.17×4.28×0.56×0.36×
Current ratio2.491.271.381.803.435.143.432.002.561.94

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.